03/09/2026
Hypothyroidism is a condition that affects millions of people worldwide, with a marked prevalence in women.
This presents a significant challenge, requiring an approach that is increasingly attentive to individual needs.
At the 47th Congress of the European Thyroid Association (ETA), IBSA contributed to the international scientific debate on the future of hypothyroidism treatment, with a focus on the role of precision medicine and personalised treatment.
For IBSA, Caring Innovation means precisely this: listening to the needs of the scientific community and patients to offer solutions that are better suited to people’s health needs.
🔹Find out all the details in our latest news item: https://www.ibsagroup.com/media/news/2026/ibsa-at-the-eta-congress-2026-new-perspectives-for-thyroid-health.html
IBSA brings its Caring Innovation approach in endocrinology, promoting scientific exchange on new perspectives in the management of thyroid disorders.